| Publication | Date of Publication | Type |
|---|
Inference on controlled effects for assessing immune correlates of protection based on a Cox model
Statistics in Medicine | 2026-02-18 | Paper |
Data Fusion Using Weakly Aligned Sources
Journal of the American Statistical Association | 2026-01-07 | Paper |
Generalized nonparametric temporal modeling of recurrent events with application to a malaria vaccine trial
Biometrics | 2025-12-16 | Paper |
Calibration weighted estimation of semiparametric transformation models for two-phase sampling
Statistics in Medicine | 2025-11-10 | Paper |
Addressing confounding and continuous exposure measurement error using corrected score functions
Biometrics | 2025-11-06 | Paper |
Estimation and hypothesis testing of strain-specific vaccine efficacy with missing strain types with application to a COVID-19 vaccine trial
Statistics in Medicine | 2025-10-17 | Paper |
Assessing variable importance in survival analysis using machine learning
Biometrika | 2025-10-15 | Paper |
Optimal auxiliary-covariate-based two-phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials
Statistics in Medicine | 2025-10-09 | Paper |
Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpoints
Statistics in Medicine | 2025-10-09 | Paper |
Power/sample size calculations for assessing correlates of risk in clinical efficacy trials
Statistics in Medicine | 2025-08-01 | Paper |
A Framework for Leveraging Machine Learning Tools to Estimate Personalized Survival Curves
Journal of Computational and Graphical Statistics | 2025-06-24 | Paper |
Correction to: ``Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpoints''
Statistics in Medicine | 2025-04-14 | Paper |
Improved estimation of the cumulative incidence of rare outcomes
Statistics in Medicine | 2025-02-25 | Paper |
Regression analysis of semiparametric Cox-Aalen transformation models with partly interval-censored data
Electronic Journal of Statistics | 2025-01-31 | Paper |
Commentary on ``Principal stratification -- a goal or a tool?'' by Judea Pearl
The International Journal of Biostatistics | 2024-11-27 | Paper |
A hybrid approach for the stratified mark-specific proportional hazards model with missing covariates and missing marks, with application to vaccine efficacy trials
Journal of the Royal Statistical Society. Series C. Applied Statistics | 2024-11-21 | Paper |
Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to human immunodeficiency virus vaccine efficacy trials
Journal of the Royal Statistical Society. Series C. Applied Statistics | 2024-11-14 | Paper |
Simultaneous inference of treatment effect modification by intermediate response endpoint principal strata with application to vaccine trials
The International Journal of Biostatistics | 2024-11-12 | Paper |
A varying-coefficient partially linear transformation model for length-biased data with an application to HIV vaccine studies
The International Journal of Biostatistics | 2024-11-12 | Paper |
Semiparametric regression analysis of partly interval-censored failure time data with application to an AIDS clinical trial
Statistics in Medicine | 2024-10-29 | Paper |
Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trials
Statistics in Medicine | 2024-10-29 | Paper |
A semiparametric Cox-Aalen transformation model with censored data
Biometrics | 2024-08-19 | Paper |
Inference for Treatment-Specific Survival Curves Using Machine Learning
Journal of the American Statistical Association | 2024-07-05 | Paper |
Estimation of conditional cumulative incidence functions under generalized semiparametric regression models with missing covariates, with application to analysis of biomarker correlates in vaccine trials
The Canadian Journal of Statistics | 2023-11-02 | Paper |
Efficient nonparametric inference on the effects of stochastic interventions under two‐phase sampling, with applications to vaccine efficacy trials
Biometrics | 2023-10-30 | Paper |
Nonparametric Estimation of the Causal Effect of a Stochastic Threshold-Based Intervention
Biometrics | 2023-10-30 | Paper |
Semiparametric Additive Time-Varying Coefficients Model for Longitudinal Data with Censored Time Origin
Biometrics | 2023-10-30 | Paper |
A General Framework for Inference on Algorithm-Agnostic Variable Importance
Journal of the American Statistical Association | 2023-10-18 | Paper |
Nonparametric variable importance assessment using machine learning techniques
Biometrics | 2023-10-09 | Paper |
Rejoinder to “Nonparametric variable importance assessment using machine learning techniques”
Biometrics | 2023-10-09 | Paper |
Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption
The Annals of Applied Statistics | 2022-09-05 | Paper |
Semiparametric Estimation of Treatment Effects Given Base-Line Covariates on an Outcome Measured After a Post-Randomization Event Occurs
Journal of the Royal Statistical Society Series B: Statistical Methodology | 2022-07-11 | Paper |
Causal Isotonic Regression
Journal of the Royal Statistical Society Series B: Statistical Methodology | 2022-07-08 | Paper |
Causal Isotonic Regression
Journal of the Royal Statistical Society Series B: Statistical Methodology | 2022-07-08 | Paper |
A multiple imputation approach for the evaluation of surrogate markers in the principal stratification causal inference framework
Risk Assessment and Evaluation of Predictions | 2021-04-20 | Paper |
General regression model for the subdistribution of a competing risk under left-truncation and right-censoring
Biometrika | 2021-01-21 | Paper |
Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes
Lifetime Data Analysis | 2021-01-18 | Paper |
Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data
Biostatistics | 2020-08-04 | Paper |
| Assessing trends in vaccine efficacy by pathogen genetic distance | 2020-07-13 | Paper |
Analysis of generalized semiparametric mixed varying‐coefficients models for longitudinal data
The Canadian Journal of Statistics | 2020-04-28 | Paper |
New approaches for censored longitudinal data in joint modelling of longitudinal and survival data, with application to HIV vaccine studies
Lifetime Data Analysis | 2019-10-01 | Paper |
Nonparametric inference for immune response thresholds of risk in vaccine studies
The Annals of Applied Statistics | 2019-08-15 | Paper |
Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy
Epidemiologic Methods | 2019-07-11 | Paper |
Doubly robust nonparametric inference on the average treatment effect
Biometrika | 2019-06-24 | Paper |
Smoothed rank regression for the accelerated failure time competing risks model with missing cause of failure
STATISTICA SINICA | 2019-02-28 | Paper |
Analysis of generalized semiparametric regression models for cumulative incidence functions with missing covariates
Computational Statistics and Data Analysis | 2018-08-17 | Paper |
Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark
Computational Statistics and Data Analysis | 2018-08-15 | Paper |
Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trials
Biometrical Journal | 2018-05-31 | Paper |
Mark-specific hazard ratio model with missing multivariate marks
Lifetime Data Analysis | 2017-08-17 | Paper |
Model-robust inference for continuous threshold regression models
Biometrics | 2017-07-21 | Paper |
Generalized semiparametric varying-coefficient model for longitudinal data with applications to adaptive treatment randomizations
Biometrics | 2017-07-21 | Paper |
Analysis of two-phase sampling data with semiparametric additive hazards models
Lifetime Data Analysis | 2017-07-17 | Paper |
Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling
Lifetime Data Analysis | 2017-05-23 | Paper |
Nonparametric bounds and sensitivity analysis of treatment effects
Statistical Science | 2016-03-04 | Paper |
Nonparametric bounds and sensitivity analysis of treatment effects
Statistical Science | 2016-03-04 | Paper |
Mark-specific hazard ratio model with missing multivariate marks
Lifetime Data Analysis | 2015-10-28 | Paper |
Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials
Journal of the American Statistical Association | 2013-11-11 | Paper |
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy
Biometrics | 2013-09-05 | Paper |
Design and estimation for evaluating principal surrogate markers in vaccine trials
Biometrics | 2013-09-05 | Paper |
Simultaneous inferences of HIV vaccine effects on viral load, CD4 cell counts, and antiretroviral therapy initiation in phase 3 trials
Deterministic and Stochastic Models of AIDS Epidemics and HIV Infections with Intervention | 2013-07-31 | Paper |
Partially hidden Markov model for time-varying principal stratification in HIV prevention trials
Journal of the American Statistical Association | 2013-04-22 | Paper |
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy
Biometrics | 2013-02-19 | Paper |
Assessing treatment-selection markers using a potential outcomes framework
Biometrics | 2012-11-19 | Paper |
Estimation of stratified mark-specific proportional hazards models with missing marks
Scandinavian Journal of Statistics | 2012-09-01 | Paper |
Comparing biomarkers as principal surrogate endpoints
Biometrics | 2012-06-20 | Paper |
Quantile regression for competing risks data with missing cause of failure
Statistica Sinica | 2012-05-14 | Paper |
Sensitivity analyses comparing time-to-event outcomes only existing in a subset selected postrandomization and relaxing monotonicity
Biometrics | 2011-11-21 | Paper |
Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials
Biometrics | 2011-03-01 | Paper |
Simultaneous Inferences on the Contrast of Two Hazard Functions with Censored Observations
Biometrics | 2011-03-01 | Paper |
Flexible Weighted Log-Rank Tests Optimal for Detecting Early and/or Late Survival Differences
Biometrics | 2011-03-01 | Paper |
Omnibus tests for comparison of competing risks with adjustment for covariate effects
Biometrics | 2011-03-01 | Paper |
Statistical identifiability and the surrogate endpoint problem, with application to vaccine trials
Biometrics | 2011-02-17 | Paper |
Assessing vaccine effects in repeated low-dose challenge experiments
Biometrics | 2010-01-21 | Paper |
Proportional hazards models with continuous marks
The Annals of Statistics | 2009-02-25 | Paper |
Proportional hazards models with continuous marks
The Annals of Statistics | 2009-02-25 | Paper |
Weighted Likelihood Method for Grouped Survival Data in Case–Cohort Studies with Application to HIV Vaccine Trials
Biometrics | 2008-12-22 | Paper |
Evaluating Candidate Principal Surrogate Endpoints
Biometrics | 2008-12-22 | Paper |
Testing and Estimation of Time‐Varying Cause‐Specific Hazard Ratios with Covariate Adjustment
Biometrics | 2008-12-22 | Paper |
The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
Biostatistics | 2008-09-25 | Paper |
Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model
The Annals of Applied Statistics | 2008-04-30 | Paper |
Nonparametric Estimation of the Joint Distribution of a Survival Time Subject to Interval Censoring and a Continuous Mark Variable
Biometrics | 2008-04-29 | Paper |
Genome Scanning Tests for Comparing Amino Acid Sequences Between Groups
Biometrics | 2008-03-20 | Paper |
Endpoints in vaccine trials
Statistical Methods in Medical Research | 2007-11-05 | Paper |
Some statistical issues in the design of HIV-1 vaccine and treatment trials
Statistical Methods in Medical Research | 2007-11-01 | Paper |
Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization
Journal of the American Statistical Association | 2007-09-18 | Paper |
A Modified False Discovery Rate Multiple-Comparisons Procedure for Discrete Data, Applied to Human Immunodeficiency Virus Genetics
Journal of the Royal Statistical Society Series C: Applied Statistics | 2007-09-07 | Paper |
Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials
Biometrics | 2006-10-12 | Paper |
Two‐Sample Tests for Comparing Intra‐Individual Genetic Sequence Diversity between Populations
Biometrics | 2006-01-03 | Paper |
Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiation
Biostatistics | 2005-09-29 | Paper |
Statistical Methods for Assessing Differential Vaccine Protection Against Human Immunodeficiency Virus Types
Biometrics | 2005-04-11 | Paper |
Tests for comparing mark-specific hazards and cumulative incidence functions
Lifetime Data Analysis | 2005-01-17 | Paper |
Goodness-of-fit tests for semiparametric biased sampling models
Journal of Statistical Planning and Inference | 2003-12-14 | Paper |
Large sample theory of maximum likelihood estimates in semiparametric biased sampling models.
The Annals of Statistics | 2002-11-14 | Paper |
| Applications of semiparametric biased sampling models to AIDS vaccine and treatment trials | 2002-05-13 | Paper |
Semiparametric efficient estimation in the generalized odds-rate class of regression models for right-censored time-to-event data
Lifetime Data Analysis | 2000-08-10 | Paper |
Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials
Biometrika | 1999-07-05 | Paper |
